Infectious complications have been considered as a major cause of morbidity and mortality
after kidney transplantation, especially in the Asian population. Therefore, prevention, early …

Background Bloodstream infection (BSI) represents an important source of morbidity and
mortality, as well as an increasing therapeutic challenge, among solid organ transplant …

Organ procurement from infected donors may transmit a disease to the recipient that could
cause a graft loss and/or recipient morbidity. Retrospectively, all kidney transplants from …

The challenges of infection in transplantation: donor-derive... : Current Opinion in Organ
Transplantation The challenges of infection in transplantation: donor-derived infections …

In 2005, more than 28,000 solid organ transplants were performed in the United States [1].
Accompanying the life-saving organ transplant for each of these patients was the …

In recent years, major progress has been made in the development, investigation and
clinical application of novel immunosuppressive drug therapies to prevent acute rejection …

Considerable progress has been made in elucidating the factors involved in the
pathogenesis of infection in the organ transplant patient. One of the general principles that …

Infection and rejection, the two major barriers to successful organ transplantation, are
closely linked, with immunosuppressive therapy being central to the pathogenesis of both …

Over the past quarter century, tremendous technological advances have been made in bone
marrow and solid organ transplantation. Despite these advances, an enduring problem for …

Background: Urinary tract infections (UTI), the most common infectious complications after
kidney transplantation, are associated with poor allograft survival. Identifying its …